We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Microsaic Systems Plc | LSE:MSYS | London | Ordinary Share | GB00BMWC8365 | ORD GBP0.00001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.975 | 0.95 | 1.00 | 0.975 | 0.975 | 0.98 | 133,735 | 07:30:42 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Components, Nec | 1.57M | -2.29M | -0.0128 | -0.76 | 1.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/1/2018 12:41 | did you sell at 3.2 then monkeynuts? lol | bobmonkeyhouse | |
25/1/2018 12:41 | We'll see who is right. Absent a placing there will be a Going Concern statement in upcoming Results. | the stigologist | |
25/1/2018 12:36 | Stigologist, come on geez. I would expect better. Think MMs took the price up just to get extra free stock as they have a buyer in the wings! | k1ngkonggb | |
25/1/2018 12:08 | Ps i don't think the ex CEO of Skepharma would have joined the Board this month if he thought the company was going to the wall...do you???....Pmsl....gl :-) | moneymunch | |
25/1/2018 12:05 | Lol..you're sounding desperate now...and guess we'll find out soon enough on the next update/ trading statement...gl :-) | moneymunch | |
25/1/2018 11:57 | or they're recruiting because people have left having seen writing on the wall | the stigologist | |
25/1/2018 11:52 | Microsaic are recruiting a whole new team of scientists and engineers, a sure sign of confidence and expectations that their business is growing and anticipation of increased production and commercialisation imho..Gla holders ;-) Microsaic @Microsaic · Jan 12 We're recruiting scientists and engineers! See our careers page: (link: #massspec #biologics #bioprocessing | moneymunch | |
25/1/2018 11:49 | 28/9/17 OUTLOOK The Board sees significant opportunities for its MS instruments being integrated into multiple areas of bioprocessing, and for diagnostics in the longer term. The Company is transforming the way it operates. It has a vision to help solve some of the major problems in human health. To do this, the Company aims to work with global partners with similar aspirations, which are prepared to co-fund R&D development costs and ensure that new product opportunities are adequately validated so they meet customer needs. The Company expects its full year 2017 revenue to be significantly lower than 2016. The shortfall in revenue is expected to be off-set by lower overheads as a result of cost reduction plans implemented in H1 2017 and that the full year loss before tax will be broadly in line with 2016. Progress has been made in addressing the difficult trading conditions and H2 2017 revenues are anticipated to be above H1 2017 based on current Q3 performance. | moneymunch | |
25/1/2018 11:43 | Verbatim from the last Results Statement Statement of Cash Flows: The comprehensive loss for the period was lower in H1 2017 compared with last year by £220,776, principally due to operating expense savings which were partly off-set by a fall in gross profit. However, after adjustments for non-cash items plus an outflow on working capital, net cash used in operating activities for H1 2017 of £1,623,043, is in line with H1 2016. Net cash used in investing activities in H1 2017 of £26,718 compares with £22,889 in H1 2016. The main movement was in interest received which was £3,572 lower in H1 2017. The net decrease in cash and cash equivalents in H1 2017 amounted to £1,649,761 compared with a decrease for the same period last year of £1,653,093. The closing cash balance at 30 June 2017 is £4,078,783. | the stigologist | |
25/1/2018 11:42 | Not looking good here guys. Cash burn on a six monthly basis £1.7m If they had £4m at End June 30th I expect they had only £2.3m at y/e Calendar 2017 So they will go into Final Results statement with Cash £2.3m (and depleting) Cash burn annualised £3m-£.6m That means Going Concern statement in Final Results. | the stigologist | |
25/1/2018 11:37 | Market cap under £6m, up to £4m cash in the bank and on going cash revenue stream from the sale of product and consumables to existing customers and OEM'S, and revenues are expected to be much improved H2 2017, and so a positive trading statement possible at anytime...Peter Grant ex CEO of Skypharma who was instrumental during their meteoric rise and subsequent £440m merger, and of course an ongoing technology collaboration with a global biopharma partner with Microsaic's technology already confirmed to being integrated into their products and equipment and already validated by their partner's BIG pharma end users....a multi-bag in the making.....and plenty of upside in anticipation, especially on further good news....Trading statement, TR1, and technology development and or new contract news...Gla..:-) | moneymunch | |
25/1/2018 11:09 | FFS- how many UKOG widows do we have here? Shame you lost money and all, but best to make your own decisions rather than be influenced by other individuals whether pro or negative. | podium | |
25/1/2018 11:05 | moneky nuts many people 50 or 60% down on UKOG when you were selling and posting every 5 minutes how it was going to a pound. Now 3p. You are a disgrace | bobmonkeyhouse | |
25/1/2018 10:51 | STOP LYING STIG | jungmana | |
25/1/2018 10:46 | re MSYS Annual overheads £3.67m If they only have £3m of cash there is a Going Concern statement coming their way "Reduced the Company's cost base and closely managed cash flow; overheads at £3.67m are approximately 16% below last year " | the stigologist | |
25/1/2018 10:37 | Spectre, yes we need an update especially with the new top man ( ex skyepharma) in charge. We should do well here medium term.Good luck to us | jungmana | |
25/1/2018 10:36 | Happy if you are Harry...Gl :-))) | moneymunch | |
25/1/2018 10:36 | Happy if you are Harry...Gl :-))) | moneymunch | |
25/1/2018 10:34 | what makes you think im not invested here mm? | trapissed monk | |
25/1/2018 10:27 | 5p here we come!±!&plusm | jayj4u | |
25/1/2018 10:27 | Welcome on board Spectre. I hold 240k shares here | jungmana | |
25/1/2018 10:05 | Lol sub 3p was short lived Mr Monk...why don't you buy some for the ride, you won't regret it imho...gl ;-) Ps Bobby the Baboon with the red squirming face...tell me what lies i have said on Ukog...oil exploration is high risk...I never said it was guaranteed, although BB could still come up trumps otherwise Ukog have got HH to look forward to...my message at Ukog was significant upside "on" confirmation of commercial flow...the same message from sub 1p...Ukog's share price remained at 7p plus for weeks and weeks after briefly hitting double figures...significan | moneymunch |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions